Well-known as an international interactive company in the biopharmaceutical market, Nanogen Biopharmaceutical Company exhibited in CPhI Worldwide 2013, from 22th to 24th October 2013 at Messe Frankfurt, Germany.
The CPhI Worldwide Exhibition offered an international platform for the chemical, pharmaceutical and biopharmaceutical manufacturers to introduce advanced range of chemicals, products, services and equipments. The exhibitors could meet their customers and partners face-to-face, exchange the supply-demand information and possibly close a new business contract.
In the CPhI 2013, Dr. Ho Nhan, our founder and CEO, introduced the current products, such as Feronsure, Pegnano, Ficocyte, Pegcyte, Nanokine and disclosed the upcoming products, such as Nanercept, Pegfilgrastim and anti-cancer monoclonal antibodies. Nanogen also offers opportunities for technique transfers and API supplies worldwide.
Our customers and partners continue to choose Nanogen’s products known for their consistent quality and competitive prices. Nanogen also announced initial plans to build a new factory with EU-GMP standards which would open various business opportunities.
Furthermore, Mr. Vipul Dholia, Head of International Business, received many positive feedback from current customers and partners for cooperations over the last year and asked for a long-term partnership. This emphasizes the sustainable development strategy that Dr. Ho Nhan established for Nanogen.
Nanogen appreciates all of our visitors who came by our booth in support at CPhI Worldwide 2013 in Frankfurt, Germany. We are looking forward to seeing you again at CPhI Worldwide 2014 in Paris, France!
For images from the conference, please see our media gallery!
.JPG)
